Robert Folkes - PetVivo Holdings Chief Officer
| PETVDelisted Stock | USD 2.09 0.10 4.57% |
Insider
Robert Folkes is Chief Officer of PetVivo Holdings
| Age | 61 |
| Phone | 952 405 6216 |
| Web | https://www.petvivo.com |
PetVivo Holdings Management Efficiency
The company has return on total asset (ROA) of (2.0774) % which means that it has lost $2.0774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.6646) %, meaning that it created substantial loss on money invested by shareholders. PetVivo Holdings' management efficiency ratios could be used to measure how well PetVivo Holdings manages its routine affairs as well as how well it operates its assets and liabilities.PetVivo Holdings currently holds 345.33 K in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. PetVivo Holdings has a current ratio of 4.07, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about PetVivo Holdings' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard Ginn | Tenon Medical | 59 | |
| Alan Connaughton | LENSAR Inc | 53 | |
| Mark Feinberg | Bluejay Diagnostics | N/A | |
| Leigh Salvo | IRIDEX | N/A | |
| Fuad Ahmad | IRIDEX | 55 | |
| Joel Bradus | Nexalin Technology | N/A | |
| Marilyn Elson | Nexalin Technology | 72 | |
| John Esq | Ainos Inc | 57 | |
| Kenneth CPA | Bluejay Diagnostics | 44 | |
| Mark MD | Bluejay Diagnostics | N/A | |
| Jason Cook | Bluejay Diagnostics | 43 | |
| Kevin Vance | Bluejay Diagnostics | 67 | |
| Craig Glynn | enVVeno Medical Corp | 64 | |
| Patrick Mercer | IRIDEX | 53 | |
| Benedict MD | enVVeno Medical Corp | 68 | |
| Warren Hancock | enVVeno Medical Corp | N/A | |
| HuiLan Wu | Ainos Inc | 63 | |
| David MD | Nexalin Technology | 63 | |
| Kendra Wong | LENSAR Inc | 45 | |
| Robert Berman | enVVeno Medical Corp | 62 | |
Management Performance
| Return On Equity | -12.66 | ||||
| Return On Asset | -2.08 |
PetVivo Holdings Leadership Team
Elected by the shareholders, the PetVivo Holdings' board of directors comprises two types of representatives: PetVivo Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PetVivo. The board's role is to monitor PetVivo Holdings' management team and ensure that shareholders' interests are well served. PetVivo Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PetVivo Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Dolan, CFO, Treasurer, Secretary, Director | ||
| Robert Folkes, Chief Officer | ||
| Randall Meyer, COO, Director | ||
| Gary DeMel, Executive Development | ||
| Russell Siakel, Director Marketing | ||
| Mark Middleton, National Sales | ||
| Randy Wenthold, Chief Science Officer | ||
| Garry Lowenthal, Chief Officer | ||
| John Lai, CEO, Director |
PetVivo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PetVivo Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.66 | ||||
| Return On Asset | -2.08 | ||||
| Operating Margin | (3.58) % | ||||
| Current Valuation | 18.79 M | ||||
| Shares Outstanding | 16.77 M | ||||
| Shares Owned By Insiders | 37.50 % | ||||
| Shares Owned By Institutions | 4.86 % | ||||
| Number Of Shares Shorted | 129.1 K | ||||
| Price To Earning | (5.76) X | ||||
| Price To Book | 19.52 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in PetVivo Stock
If you are still planning to invest in PetVivo Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PetVivo Holdings' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |